305 related articles for article (PubMed ID: 7730365)
1. Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors.
Alonso G; Koegl M; Mazurenko N; Courtneidge SA
J Biol Chem; 1995 Apr; 270(17):9840-8. PubMed ID: 7730365
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the SH2 binding specificity and kinase activity of Src by tyrosine phosphorylation within its SH2 domain.
Stover DR; Furet P; Lydon NB
J Biol Chem; 1996 May; 271(21):12481-7. PubMed ID: 8647855
[TBL] [Abstract][Full Text] [Related]
3. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
[TBL] [Abstract][Full Text] [Related]
5. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
[TBL] [Abstract][Full Text] [Related]
6. Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor.
Courtneidge SA; Dhand R; Pilat D; Twamley GM; Waterfield MD; Roussel MF
EMBO J; 1993 Mar; 12(3):943-50. PubMed ID: 7681396
[TBL] [Abstract][Full Text] [Related]
7. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Bibbins KB; Boeuf H; Varmus HE
Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
[TBL] [Abstract][Full Text] [Related]
8. Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation.
Twamley GM; Kypta RM; Hall B; Courtneidge SA
Oncogene; 1992 Oct; 7(10):1893-901. PubMed ID: 1408131
[TBL] [Abstract][Full Text] [Related]
9. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
10. PDGF-induced phosphorylation of Tyr28 in the N-terminus of Fyn affects Fyn activation.
Hansen K; Alonso G; Courtneidge SA; Rönnstrand L; Heldin CH
Biochem Biophys Res Commun; 1997 Dec; 241(2):355-62. PubMed ID: 9425276
[TBL] [Abstract][Full Text] [Related]
11. The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding.
Broome MA; Hunter T
Oncogene; 1997 Jan; 14(1):17-34. PubMed ID: 9010229
[TBL] [Abstract][Full Text] [Related]
12. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
Roussel RR; Brodeur SR; Shalloway D; Laudano AP
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10696-700. PubMed ID: 1720546
[TBL] [Abstract][Full Text] [Related]
13. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
[TBL] [Abstract][Full Text] [Related]
14. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling.
Broome MA; Hunter T
J Biol Chem; 1996 Jul; 271(28):16798-806. PubMed ID: 8663329
[TBL] [Abstract][Full Text] [Related]
15. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells.
Twamley-Stein GM; Pepperkok R; Ansorge W; Courtneidge SA
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7696-700. PubMed ID: 8356071
[TBL] [Abstract][Full Text] [Related]
16. Phosphopeptide occupancy and photoaffinity cross-linking of the v-Src SH2 domain attenuates tyrosine kinase activity.
Garcia P; Shoelson SE; Drew JS; Miller WT
J Biol Chem; 1994 Dec; 269(48):30574-9. PubMed ID: 7527032
[TBL] [Abstract][Full Text] [Related]
17. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
18. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.
Isakov N; Wange RL; Burgess WH; Watts JD; Aebersold R; Samelson LE
J Exp Med; 1995 Jan; 181(1):375-80. PubMed ID: 7528772
[TBL] [Abstract][Full Text] [Related]
19. Raf-1 interacts with Fyn and Src in a non-phosphotyrosine-dependent manner.
Cleghon V; Morrison DK
J Biol Chem; 1994 Jul; 269(26):17749-55. PubMed ID: 7517401
[TBL] [Abstract][Full Text] [Related]
20. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
